Literature DB >> 3188661

A pilot study of community cholesterol screening.

C Scheidt-Nave1, E Barrett-Connor, M H Criqui, K T Khaw.   

Abstract

We tested the feasibility and effectiveness of population cholesterol screening in a California shopping center. Total plasma cholesterol (TC) was measured in 429 adults from capillary blood samples, using automatic analyzers (Reflotron). A self-administered questionnaire was used to ascertain demographic variables, lifestyle, and knowledge about cholesterol and heart disease. According to NIH Consensus Conference criteria, 20% of all screenees showed moderate or high risk TC levels, but over half of these had a history of hypercholesterolemia prior to testing. Follow-up of all screenees with TC levels at 220 mg/dl and greater revealed that 32% had been compliant with our advice to contact their physician. Physicians expressed no concern in 71% of those with TC elevation of 220-239 mg% and in 30% of those with TC levels 240+ mg%. Of all participants, 40% reported dietary changes in response to the screening; 78% of this group, however, made changes without a physician's advice. In our experience community cholesterol screening is popular and feasible. Efficacy, however, must be improved by better education of physician and the public.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3188661     DOI: 10.1007/bf02083576

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN: 0303-8408


  18 in total

1.  Promoting preventive care: changing reimbursement is not enough.

Authors:  S J McPhee; S A Schroeder
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

2.  Factors influencing physicians' orientation toward prevention.

Authors:  B Maheux; R Pineault; F Béland
Journal:  Am J Prev Med       Date:  1987 Jan-Feb       Impact factor: 5.043

3.  Feasibility of large-scale cholesterol screening: experience with a portable capillary-blood testing device.

Authors:  P Greenland; J C Levenkron; M G Radley; J G Baggs; R A Manchester; N L Bowley
Journal:  Am J Public Health       Date:  1987-01       Impact factor: 9.308

4.  Consensus conference. Lowering blood cholesterol to prevent heart disease.

Authors: 
Journal:  JAMA       Date:  1985-04-12       Impact factor: 56.272

5.  Survey of physician and patient nutrition education needs.

Authors:  C I Modrow; C W Miles; S Koerin; S K Dobek; P Book; L Honaker
Journal:  J Am Diet Assoc       Date:  1980-12

6.  Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men.

Authors:  I Hjermann; K Velve Byre; I Holme; P Leren
Journal:  Lancet       Date:  1981-12-12       Impact factor: 79.321

Review 7.  Tobacco and health: trends in smoking and smokeless tobacco consumption in the United States.

Authors:  J M McGinnis; D Shopland; C Brown
Journal:  Annu Rev Public Health       Date:  1987       Impact factor: 21.981

8.  Frequency and clustering of nonlipid coronary risk factors in dyslipoproteinemia. The Lipid Research Clinics Program Prevalence Study.

Authors:  M H Criqui; L D Cowan; G Heiss; W L Haskell; P M Laskarzewski; L E Chambless
Journal:  Circulation       Date:  1986-01       Impact factor: 29.690

9.  Cholesterol and mortality. 30 years of follow-up from the Framingham study.

Authors:  K M Anderson; W P Castelli; D Levy
Journal:  JAMA       Date:  1987-04-24       Impact factor: 56.272

10.  The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study.

Authors:  J Stokes; W B Kannel; P A Wolf; L A Cupples; R B D'Agostino
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

View more
  1 in total

1.  Frequency of consumption of selected indicator foods and serum cholesterol. GISSI-EFRIM investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto--Epidemiologia dei Fattori di Rischio dell'Infarto Miocardico.

Authors:  B D'Avanzo; E Negri; A Nobili; C La Vecchia
Journal:  Eur J Epidemiol       Date:  1995-06       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.